ProMab Biotechnologies is a company that develops and commercializes recombinant proteins, antibodies, and engineered cell lines through the integration of bioinformatics, molecular biology, protein expression, purification techniques, gene cloning, microbiology, and immunology. It provides its proprietary proteins to deliver research and diagnostic products, as well as services for the biomedical research community.